Abstract
Bacteriuria ofStenotrophomonas maltophilia, a new name forXanthomonas maltophilia, is not common. During a 7-year study period, the medical records of 26 patients were retrospectively analized. All patients had several underlying diseases and previous antimicrobial treatments.S. maltophilia spontaneously regressed and was thought to be colonized in most of our patients. This organism is resistant to most broad-spectrum antibiotics, except for minocycline and latamoxef. AlthoughS. maltophilia is thought to be a colonizer in the urinary tract, it should be viewed with special concern because of its resistance to antibiotics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Palleroni NJ, Bradbury JF.Stenotrophomonas, a new bacterial genus forXanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Sys Bacteriol 1993;43:606–609.
Rosenthal SL. Sources ofPseudomonas andAcinetobacter species found in human culture materials. Am J Clin Pathol 1974;62:807–811.
Marshall WF, Keating MR, Anhalt JP. Steckelberg JM.Xanthomonas maltophilia. An emerging nosocomial pathogen. Mayo Clin Proc 1989;64:1097–1104.
Morrison AJ Jr, Hoffmann KK, Wenzel RP. Associated mortality and clinical characteristics of nosocomialPseudomonas maltophilia in a university hospital. J Clin Microb 1986;24:52–55.
Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due toXanthomonas maltophilia (Pseudomonas maltophlia) in patients with cancer. Rev Infect Dis 1990;12:997–1003.
Wishart MM, Riley TV. Infection withPseudomonas maltophilia—hospital outbreak due to contaminated disinfectant. Med J Aust 1976;2:710–712.
Elting LS, Bodey GP. Septicemia due toXanthomonas species and non-aeruginosaPseudomonas species: increasing incidence of catheter-related infections. Medicine 1990;69:296–306.
Vartivarian SE, Papadakis KA, Palacios JA, Manning JT Jr, Anaissie EJ. Mucocutaneous and soft tissue infections caused byXanthomonas maltophilia. A new spectrum. Ann Intern Med 1994;121:969–973.
Laing FPY, Ramotar K, Read RR, Alfieri N, Kureishi A, Henderson EA, et al. Molecular epidemiology ofXanthomonas maltophilia colonization and infection in the hospital environment. J Clin Microb 1995;33:513–518.
Mett H, Rosta S, Schacher B, Frei R. Outer membrane permeability and β-lactamase content inPseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis 1988;10:765–769.
Akova M, Bonfiglio G, Livermore DM. Susceptibility to β-lactam antibiotics of mutant strains ofXanthomonas maltophilia with high and low-level constitutive expression of L1 and L2 β-lactamases. J Med Microbiol 1991; 35:208–213.
Garcia-Rodriguez JA, Sanchez JEG, Garcia MIG, Sanchez EG, Bellido JLM. Antibiotic susceptibility profile ofXanthomonas maltophilia. In vitro activity of β-lactam/β-lactamase inhibitor combinations. Diagn Microbiol Infect Dis 1991;14:239–243.
Smit WJ, Boquest AL, Geddes JE, Tosolini FA. The antibiotic susceptibilities ofXanthomonas maltophilia and their relation to clinical management. Pathology 1994;26:321–324.
Author information
Authors and Affiliations
About this article
Cite this article
Ishihara, S., Yasuda, M., Nakano, M. et al. Significance ofStenotrophomonas maltophilia in urinary tract infections. J Infect Chemother 4, 20–23 (1998). https://doi.org/10.1007/BF02490061
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02490061